Document is current
Any future updates will be listed below
-
Authors
Zheng, Yi https://orcid.org/0000-0001-9579-1711
Zhang, Xuejing
Hou, Jinxiu
Guo, Qian
Qin, Zhenzhi
Yang, Huiyu
Zhao, Xianghe
Zhou, Panpan
Yuan, Shuofeng https://orcid.org/0000-0001-7996-1119
Gao, Chengjiang https://orcid.org/0000-0002-9365-4497
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (82271788)
- License Information
-
More Information
Article History
Received: 26 May 2025
Accepted: 15 April 2026
First Online: 28 April 2026
Competing interests
: The authors declare the following competing interests: A Chinese patent application related to a compound targeting CSDE1 phase separation and its antiviral application has been filed by Shandong University. The inventors are C.G., Y.Z., X.Z., S.Y., and Q.G. The application number is 202512029127.7, and its status is pending. This patent covers the compound and therapeutic applications described in this manuscript. All other authors declare no competing interests.
